Here are three things to know:
1. The device manufacturer’s $1 million expansion will double the size of its warehouse headquarters and create additional office space as well as training and education facilities.
2. OrthoPediatrics will break ground on the expansion Aug. 16.
3. OrthoPediatrics has grown revenue at least 20 percent annually for the past decade and reported 28 percent revenue growth last quarter, according to company CEO Mark Throdahl.
“Since our IPO in October 2017, we have been aggressively investing in growth initiatives, including hiring additional associates, tripling the deployment of consigned implant/instrument sets, increasing our investment in [research and development] and expanding our clinical education programs,” Mr. Throdahl said
More articles on devices and implants:
28 spine devices receive FDA 510(k) clearance in July
Smith & Nephew stock sees downgrade over surgical robots market concerns
3 things to know about the global interbody fusion cage market
